Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online December 27, 2007
Diabetes 57:1043-1047, 2008
DOI: 10.2337/db07-0761
© 2008 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online-Only Appendix
Right arrow All Versions of this Article:
db07-0761v1
db07-0761v2
db07-0761v3
57/4/1043    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kang, E. S.
Right arrow Articles by Lee, H. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kang, E. S.
Right arrow Articles by Lee, H. C.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

A Polymorphism in the Zinc Transporter Gene SLC30A8 Confers Resistance Against Posttransplantation Diabetes Mellitus in Renal Allograft Recipients

Eun Seok Kang1,2,3, Myoung Soo Kim4,5, Yu Seun Kim3,4,5, Chul Hoon Kim3,6, Seung Jin Han1, Sung Wan Chun1, Kyu Yeon Hur3, Chung Mo Nam7, Chul Woo Ahn1,2,3, Bong Soo Cha1,2,3, Soon Il Kim4,5, and Hyun Chul Lee1,2,3

1 Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea
2 Institute of Endocrine Research, Yonsei University College of Medicine, Seoul, Korea
3 Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea
4 Department of Surgery, Yonsei University College of Medicine, Seoul, Korea
5 The Research Institute for Transplantation, Yonsei University College of Medicine, Seoul, Korea
6 Department of Pharmacology, Yonsei University College of Medicine, Seoul, Korea
7 Department of Preventive Medicine and Public Health, Yonsei University College of Medicine, Seoul, Korea

Address correspondence and reprint requests to Hyun Chul Lee, MD, PhD, Department of Internal Medicine, Yonsei University College of Medicine, 134 Shinchon-Dong Seodaemun-Gu, Seoul, Korea 120-752; or to Soon Il Kim, MD, PhD, Department of Surgery, Yonsei University College of Medicine, 134 Shinchon-Dong Seodaemun-Gu, Seoul, Korea 120-752. E-mail: endohclee{at}yumc.yonsei.ac.kr and soonkim{at}yumc.yonsei.ac.kr

Abbreviations: FPG, fasting plasma glucose; HOMA, homeostasis model assessment; PTDM, posttransplantation diabetes mellitus; SNP, single nucleotide polymorphism; ZnT, zinc transporter

OBJECTIVE—Posttransplantation diabetes mellitus (PTDM) is a major metabolic complication in renal transplant recipients, and insulin secretory defects play an important role in the pathogenesis of PTDM. The R325W (rs13266634) nonsynonymous polymorphism in the islet-specific zinc transporter protein gene, SLC30A8, has been reported to be associated with type 2 diabetes and possibly with a defect in insulin secretion. This study investigated the association between genetic variations in the SLC30A8 gene and PTDM in renal allograft recipients.

RESEARCH DESIGN AND METHODS—A total of 624 unrelated renal allograft recipients without previously diagnosed diabetes were enrolled. Rs13266634 was genotyped in the cohort, which consisted of 174 posttransplantation diabetic patients and 450 non-posttransplantation diabetic subjects. The genotyping of the SLC30A8 polymorphism was performed using real-time PCR.

RESULTS—The prevalence of PTDM was 33.8% in patients carrying the R/R genotype, 26.8% in patients with the R/W genotype, and 19.8% in patients with the W/W genotype. There was a strong association between the number of W-alleles and PTDM risk reduction (P for trend = 0.007). Patients with at least one T-allele showed a decreased risk of PTDM compared with those with the R/R genotype (R/W, risk ratio [RR] 0.78, P = 0.126; W/W, RR 0.52, P = 0.007). The effect of the SLC30A8 genotype remained significant after adjustments for age, sex, body weight gain, and type of immunosuppressant (R/W, hazard ratio [HR] 0.77, P = 0.114; W/W, HR 0.58, P = 0.026).

CONCLUSIONS—These data provide evidence that the SLC30A8 rs13266634 gene variation is associated with protection from the development of PTDM in renal allograft recipients.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2008 by the American Diabetes Association.